Commentary on “Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel.” Peer A, Gottfried M, Sinibaldi V, Carducci MA, Eisenberger MA, Sella A, Leibowitz-Amit R, Berger R, Keizman D, Department of Oncology, Rambam Medical Center, Haifa, Israel.: Prostate 2014 Apr;74(4):433–40; doi:10.1002/pros.22765. [Epub 2013 Dec 11]

Autor: Trump, Donald

Publikováno v: In Urologic Oncology: Seminars and Original Investigations May 2016 34(5):247-247

Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer

Autor: Leibowitz-Amit, R. ^{∗, ††}, Israel, A. ^†, Gal, M. ^∗, Atenafu, E.A. ^‡, Symon, Z. ^{∗, ††}, Portnoy, O. ^{§, ††}, Laufer, M. ^¶, Dotan, Z. ^{¶, ††}, Ramon, J. ^{¶, ††}, Avni, D. ^||, Fridman, E. ^{∗∗, ††}, Berger, R. ^{∗, ††, ∗}

Publikováno v: In Clinical Oncology December 2016 28(12):790-796

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer

Autor: Leibowitz-Amit, R. ^{1, †}, Templeton, A.J. ^{1, †}, Omlin, A. ³, Pezaro, C. ³, Atenafu, E.G. ², Keizman, D. ⁴, Vera-Badillo, F. ¹, Seah, J.-A. ¹, Attard, G. ³, Knox, J.J. ¹, Sridhar, S.S. ¹, Tannock, I.F. ¹, de Bono, J.S. ³, Joshua, A.M. ^{1, *}

Publikováno v: In Annals of Oncology March 2014 25(3):657-662

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Utility of 68Ga-PSMA PET/CT in Decisions Regarding Administering Salvage Radiotherapy to Men with Prostate Cancer.

Autor: Ben Shimol J; Barzilai Medical Center, Ashqelon 7830604, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Lewin R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel., Symon Z; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel., Rosenzweig B; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Department of Urology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel., Leibowitz-Amit R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Oncology Institute, Shamir Medical Center, Zerifin 7033001, Israel., Eshet Y; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Department of Nuclear Medicine, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel., Domachevsky L; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Department of Nuclear Medicine, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel., Davidson T; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.; Department of Nuclear Medicine, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan 5262000, Israel.

Publikováno v: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Dec 29; Vol. 20 (1). Date of Electronic Publication: 2022 Dec 29.